Europe – Registered substances mapped for regulatory action

The first report of the Integrated Regulatory Strategy presents a mapping of the universe of registered substances that are on the EU market. This information helps authorities to identify, plan and monitor the progress on identifying and regulating substances of concern.

Helsinki, 17 April 2019 – The report visualises the work that ECHA and the Member States have done to transform the vast data generated under REACH into knowledge on which substances need further hazard information, further risk management measures or for which substances authorities can conclude that they are not a priority at the moment.

“Our work enables authorities to focus on activities that improve human health and the environment in Europe and make the European industry more competitive. We remind industry to further improve the compliance of their registration information, in particular for substances with a high potential for exposure and for which hazard data is currently lacking,” states ECHA’s Executive Director Bjorn Hansen.

Within the report, registered substances are divided into three main pools:

  1. High priority for risk management, covering around 270 substances. These are substances with an identified concern and for which further regulatory work is ongoing or can start based on currently available information.
  2. High priority for data generation and assessment, with around 1 300 substances of potential concern. Here further data needs to be generated or assessed to enable authorities to decide whether further regulatory risk management is needed.
  3. Low priority for further regulatory action at present. In this group, around 450 substances are considered as already sufficiently regulated and almost 500 substances have been concluded as low priority after assessment…